ARCHIVES

In Brief: Georgetown Professor Heads Cancer Therapy Evaluation Program; NCI-VA Branch Abolished

This article is from The Cancer Letter archive.

Vol. 05 No. 36 | September 7, 1979

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

60-Mile Limit For Primate Facility Dropped

June 9, 1978

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

PET Tracer Drug Approved, Developed At Weill Cornell

September 24, 2004

NCI to Advise Women in 40s o Ask Doctor About Mammography, End Routine Screening

September 24, 1993